Top Markets
Coin of the day
Synairgen plc Synairgen plc

Synairgen plc

SNG
Peringkat dalam Saham #40400
Synairgen plc specializes in the research and development of pharmaceutical... Synairgen plc specializes in the research and development of pharmaceutical treatments for various respiratory conditions. Its product pipeline includes SNG001, an inhaled interferon beta currently being developed for COVID-19. The company is also advancing an inhaled form of interferon beta (IFN-ß) through Phase II clinical trials for the management of asthma triggered by common colds and influenza, as well as for the treatment or prevention of chronic obstructive pulmonary disease. Furthermore, Synairgen is developing a LOXL2 inhibitor intended for treating idiopathic pulmonary fibrosis (IPF). To support the development of this LOXL2 inhibitor, the company maintains a licensing and collaboration agreement with Pharmaxis Ltd. Synairgen plc was established in 2004 and is headquartered in Southampton, United Kingdom.
Harga Saham
$0.01292666
Terakhir disinkronkan: 2025-04-08
Kapitalisasi Pasar
$157.54K
Perubahan (1 hari)
6.84%
Perubahan (1 tahun)
0.00%
Negara
GB
Perdagangan Synairgen plc (SNG)

Kategori

Riwayat pemecahan saham untuk Synairgen plc (SNG)
Saham Synairgen plc (simbol: SNG) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Aug 14, 2026.
Satu lembar saham SNG yang dibeli sebelum Aug 14, 2026 sekarang setara dengan 0 lembar saham SNG.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
Tidak cukup data untuk tanggal yang disediakan.
Pemecahan saham untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pemecahan saham Kelipatan Kumulatif Negara
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE